Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Immunonutrition Versus Standard Enteral Nutrition Before Major Surgery
This study is not yet open for participant recruitment.
Verified by University of Lausanne Hospitals, August 2007
Sponsors and Collaborators: University of Lausanne Hospitals
Novartis
Information provided by: University of Lausanne Hospitals
ClinicalTrials.gov Identifier: NCT00512213
  Purpose

The aim of this trial is to compare preoperative Imunnonutrition with standard enteral nutrition regarding morbidity after major abdominal surgery in patients with NRS greater 3.

The primary end point is the complication rate until 30 days after surgery.


Condition Intervention
Major Abdominal Surgery
Dietary Supplement: Immunonutrition for 5 days preoperative
Dietary Supplement: Standard enteral nutrition for 5 days preoperative

MedlinePlus related topics: Dietary Supplements
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Active Control, Parallel Assignment, Efficacy Study
Official Title: Immunonutrition Versus Standard Enteral Nutrition Before Major Surgery: A Single-Center Double-Blinded Controlled Randomized Superiority Trial

Further study details as provided by University of Lausanne Hospitals:

Primary Outcome Measures:
  • complications after surgery [ Time Frame: 30 days ]

Secondary Outcome Measures:
  • hospital stay, patient compliance, Interleukin-6 and 10 plasma level [ Time Frame: 30 days ]

Estimated Enrollment: 150
Study Start Date: September 2007
Estimated Study Completion Date: December 2008
Arms Assigned Interventions
1: Active Comparator
Immunonutrition
Dietary Supplement: Immunonutrition for 5 days preoperative
2: Active Comparator
Standard enteral nutrition
Dietary Supplement: Standard enteral nutrition for 5 days preoperative

Detailed Description:

Malnutrition affects about 20-50% of all patients in hospital [1, 2]. Major surgery further increases postoperative malnutrition and immunity reduction. Therefore, postoperative complication and infection rates after major surgery exceed 30% [3-6].

The nutritional risk score (NRS) [1] is based on the ESPEN (European society of parenteral and enteral nutrition) screening guidelines and identifies patients who are likely to benefit from nutritional support. Patients with a NRS ≥ 3 are considered severely undernourished, or to have a certain degree of severity of disease in combination with certain degree of malnutrition [7].

In a prospective cohort study patients with a NRS ³ 3 had significant more infectious and overall complications after major abdominal surgery [4, 7, 8]. Several studies showed a benefit by nutritional support on complications [3, 5, 6]. International guidelines suggest therefore preoperative oral nutritional support for malnourished patients undergoing major surgery [9]. However, it remains controversial whether standard enteral nutrition (SEN) or immunonutrition (IN) is preferable [9].

IN, containing arginine, ribonucleic acid and omega-3 polyunsaturated fatty acids aims to improve the nutritional status, immunological function and clinical outcome [5, 10].

  Eligibility

Ages Eligible for Study:   18 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • All patients admitted for elective major abdominal surgery:

    • Open and laparoscopic esophageal, gastric, hepatic, pancreatic, intestinal and colorectal surgery and with a NRS ≥ 3.

Exclusion Criteria:

  • Age < 18 years
  • No informed consent
  • Emergency situation
  • Patients not speaking french or german.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00512213

Contacts
Contact: Martin Hubner, MD +41 21 314 2418 martin.hubner@chuv.ch
Contact: Sven Muller, MD +41 21 314 2325 sven.muller@chuv.ch

Locations
Switzerland
Department of Visceral Surgery, University Hospital Center
Lausanne, Switzerland, 1011
Sponsors and Collaborators
University of Lausanne Hospitals
Novartis
Investigators
Study Chair: Nicolas Demartines, MD Department of Visceral Surgery, University Hospital Center, Lausanne, Switzerland
  More Information

Study ID Numbers: P00/07 CHV
Study First Received: August 6, 2007
Last Updated: August 6, 2007
ClinicalTrials.gov Identifier: NCT00512213  
Health Authority: Switzerland: Ethikkommission

Keywords provided by University of Lausanne Hospitals:
preoperative Immunonutrition, major abdominal surgery, complication

ClinicalTrials.gov processed this record on January 15, 2009